Parkinson hastalığının park7 -/- zebra balığı larva modelinde erken motor bozukluklar, uyku bozukluğu ve dopaminerjik nöronlarda azalma

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Abstract Parkinson's Disease (PD) is the fastest-growing neurological disorder and only symptomatic treatment is available. Zebrafish are ideally suited for high-throughput screening of disease modifying drugs and mechanistic studies. Mutations in park7 are associated with early-onset familial PD. Additionally, altered levels and subcellular location of the park7 protein product (DJ-1) have been found in PD patients without known park7 mutations. Here, we show that larval park7 −/− zebrafish show reduced number of dopaminergic neurons and motor dysfunction, similarly to the 1-methyl-4-phenylpyridinium (MPP + )-induced PD model. Additionally, PD-associated prodromal symptoms, such as reduced sensory function, increased sleep latency and daytime sleepiness, were also observed in the park7 −/− , but not in the MPP + -induced PD model. The park7 −/− is the first stable genetic zebrafish model of Parkinson’s disease which shows both motor and non-motor symptoms, together with a reduction in dopaminergic neurons, at a larval stage. The model should therefore be highly valuable as a tool for PD related drug screening and mechanistic studies.

İlgili konular